| 51 |
18346173 | Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study. | 2008 Aug |
1 |
| 52 |
17307426 | A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes. | 2007 Mar |
1 |
| 53 |
17489777 | C-reactive protein in obese PCOS women and the effect of metformin therapy. | 2007 Feb |
2 |
| 54 |
16472047 | "Anti-inflammatory" drugs and their effects on type 2 diabetes. | 2006 Feb |
1 |
| 55 |
16957566 | Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria. | 2006 Oct |
1 |
| 56 |
15855347 | Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. | 2005 May |
2 |
| 57 |
15901207 | Cardiovascular risk factors associated with insulin resistance: effects of oral antidiabetic agents. | 2005 |
1 |
| 58 |
16108864 | Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus. | 2005 Sep |
5 |
| 59 |
15236798 | AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase. | 2004 |
3 |
| 60 |
12721499 | Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome. | 2003 Apr |
5 |
| 61 |
12738395 | Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. | 2003 May-Jun |
1 |
| 62 |
14502100 | Beneficial effects of metformin on haemostasis and vascular function in man. | 2003 Sep |
1 |
| 63 |
14557435 | Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome. | 2003 Oct |
5 |